SMTL ID : 6yyg.1 (3 other biounits)

Crystal Structure of 5-(trifluoromethoxy)indoline-2,3-dione covalently bound to the PH domain of Bruton's tyrosine kinase mutant R28C

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.95 Å

Oligo State

monomer

Ligands

1 x Q1B: 5-(trifluoromethyloxy)-1,3-dihydroindol-2-one(Non-covalent)

Q1B.1: 11 residues within 4Å: Chain A: K.11, S.13, Q.14, F.29, L.36, Y.38, G.53, S.54, I.55, Y.105, L.110 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:Y.38, A:Y.38, A:L.110 Hydrogen bonds: A:Q.14, A:Y.38

1 x MG: MAGNESIUM ION(Non-covalent)

MG.2: 2 residues within 4Å: Chain A: E.84, E.95 3 PLIP interactions: 1 interactions with chain A, 2 Ligand-Water interactions Metal complexes: A:E.95, H2O.3, H2O.3

1 x ZN: ZINC ION(Non-covalent)

ZN.3: 4 residues within 4Å: Chain A: H.142, C.153, C.154, C.164 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:H.142, A:C.153, A:C.154, A:C.164

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Brear, P. et al., Optimising crystallographic systems for structure-guided drug discovery. To Be Published

Release Date

2021-05-12

Peptides

Tyrosine-protein kinase BTK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase BTK

Related Entries With Identical Sequence